San Diego, California—Binding Site’s Immunologicals Group is pleased to announce the addition of two new polyclonal sheep anti-human, affinity purified, FITC conjugated, monkey adsorbed antibodies to its broad offering of products for research applications. Both of these polyclonal antibodies have been expressly designed for use as an integral component within a variety of different testing procedures, especially enzyme immunoassays (EIAs). As such, researchers involved in the life science, drug discovery, clinical, and biopharmaceutical fields will find the availability of these products especially useful in their efforts.
Catalogue Number AF003.M is Anti-Immunoglobulin antibody; while Catalogue Number AF004.M is an Anti-IgG (Fc) targeted antibody. Both of these affinity purified, FITC conjugated antibodies demonstrate minimal species cross-reactivity with monkey serum proteins, due to insoluble adsorption techniques utilized during manufacturing. Plus, these antibodies also feature exceptional lot-to-lot consistencies and offer extended shelf life stability claims. Both are available in compact, standard-sized vials of 1.0 mg; with larger bulk configurations also being available.
Binding Site’s Immunologicals Group serves the in-vitro diagnostic (IVD) manufacturing and biopharmaceutical | clinical | life-science | medical research markets with a comprehensive line of innovative products. For additional information, contact The Binding Site, Inc. at 6730 Mesa Ridge Road, San Diego, CA 92121 USA. Phone: 800-633-4484; FAX: 858-453-9189; Email: email@example.com. Please visit our website at www.immunologicals.com.